Idiopathic Pulmonary Fibrosis Comorbidities Discussed By Researchers
A team of researchers from the Department of Clinical and Experimental Medicine at the University of Catania, Italy recently reviewed the co-occurrence of additional diseases in Idiopathic Pulmonary Fibrosis and their current therapeutic strategies. The study, entitled “IPF, comorbidities and management implications,“ was published in the Sarcoidosis Vasculitis and Diffuse Lung Disease journal.
IPF is not curable and available treatments are only used to aid patients in breathing. IPF is associated with a wide variety of comorbidities of the respiratory and non-respiratory system. In this recent study, the team focused on three common diseases linked to IPF diseases — cardiovascular disorders, lung cancer and emphysema.